Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000440

Drug Information
NameOxacillin    
SynonymsOxacilina; MPi-PC; Oxacillin [INN:BAN]; DB00713; (2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 7240-38-2 (monosodium salt, monohydrate); 5-Methyl-3-phenyl-4-isoxazolyl-penicillin; Oxacillinum [INN-Latin]; 66-79-5; (5-methyl-3-phenyl-4-isoxazolyl)penicillin; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-(((5-methyl-3-phenyl-4-isoxazolyl)carbonyl)amino)-7-oxo-, (2S-(2.alpha.,5.alpha.,6.beta.))-; 2,2-dimethyl-6beta-(5-methyl-3-phenyl-1,2-oxazole-4-carboxamido)penam-3alpha-carboxylic acid; Prostaphlin; Oxacillin, Monosodium Salt, Anhydrous; LS-149809; Prostaphlyn; (2S,5R,6R)-3,3-dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; OXACILLIN SODIUM; Ossacillina; Penicillin, (5-methyl-3-phenyl-4-isoxazolyl)-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-[[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-7-oxo-, (2S,5R,6R)-; D08307; 1173-88-2; C07334; UNII-UH95VD7V76; 1173-88-2 (anhydrous monosodium salt); CID6196; Penicillin, Methylphenylisoxazolyl; Oxacillinum; Bactocill; CHEBI:7809; EINECS 200-635-5; C19H19N3O5S; Oxazocilline; Oxacillin (INN); oxacillin; Oxacilline; Oxacilina [INN-Spanish]; Oxazocillin; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-6-(((5-methyl-3-phenyl-4-isoxazolyl)carbonyl)amino)-7-oxo-, (2S-(2alpha,5alpha,6beta))-; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-6-(5-methyl-3-phenyl-4-isoxazolecarboxamide)-7-oxo-; 6beta-(5-methyl-3-phenylisoxazol-4-yl)penicillanic acid; Ossacillina [DCIT]; MPI-penicillin; AC1L1M00; Oxacilina (TN); Oxacilline [INN-French]; CHEMBL819; Sodium oxacillin    
Trade NameBactocill    
CompanySandoz Inc    
IndicationBacterial infectionsApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAnti-Bacterial Agents    
CAS NumberCAS 66-79-5
FormularC19H19N3O5S    
PubChem Compound IDCID 6196.    
PubChem Substance IDSID 9541.    
ChEBI7809;    
SuperDrug ATC IDJ01CF04;    
SuperDrug CAS ID000066795;    
TargetPenicillin binding proteinBinder[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 061490 To Reference
Ref 2Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA. Antimicrob Agents Chemother. 2009 Jul;53(7):2871-8. Epub 2009 May 11. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543